Corporate Action29 Oct 2026, 05:22 pm
Anlon Healthcare gets 'In-Principle' approval for preferential share issuance
AI Summary
Anlon Healthcare Ltd has received 'In-Principle' approval from both NSE and BSE for the proposed issuance of 8,05,35,651 equity shares of Rs. 2/- each. This issuance is part of a share swap on a preferential basis, in accordance with Chapter V of the SEBI (ICDR) Regulations, 2018. The approvals were communicated via letters from NSE and BSE dated October 28, 2026.
Key Highlights
- Received 'In-Principle' approval from NSE and BSE.
- Proposed issuance of 8,05,35,651 equity shares.
- Issuance is on a preferential basis via share swap.
- Complies with SEBI (ICDR) Regulations, 2018.
Price Impact
More from AHCL